Guerbet’s AI-based software joins diagnostic and interventional solutions on display

Last updated Nov 16, 2023

Guerbet, a global leader in medical imaging with more than 30 years of experience in MRI, has announced its presence at the 2023 Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting from November 26-30. In addition to the Guerbet exhibit (booth #1711), the company will be presenting safety data in an abstract titled ‘Safety of gadopiclenol for magnetic resonance imaging (MRI): a pooled analysis of eight studies.’ The session number W3-STCE1, will be presented as a poster session on Wednesday, November 29, at 10:00-10:30 am CST.

In addition to its diagnostic and interventional solutions, Guerbet will share its digital and AI software-based products that offer smart connectivity between monitoring and reporting. Products featured include:

Dose & Care, a digital solution for monitoring patient exposure to x-rays that is compatible with all types of ionising modalities and collects data to provide a record of patient exposure
Contrast & Care, an injection data management solution that enables imaging centres to collect, archive, examine, and share injection data, including data on contrast products, adverse events, injector activity, information on estimated glomerular filtration rate, and other risk factors before a clinical examination
Icobrain, a cloud-based AI solution designed to quantify disease-specific brain structures on MR and CT
Galileo, an educational web-based case review platform to help train radiology residents
Myrian, a universal image processing solution that can be integrated into all healthcare information systems
OptiStar Elite, a dual-head contrast delivery system with an ultrasonic motor that makes it non-magnetic and built for long-lasting performance plus new fractional dosing capability

Visit Guerbet on stand 1711, south hall.

Picture: Guerbet will share its diagnostic and interventional solutions.

This news story has been sponsored by the companies concerned and does not represent the views or opinions of RAD Magazine. Visit our dedicated RSNA conference page to find out more.